Status:
COMPLETED
Ketamine IV Classic Protocol : Five Years Follow up
Lead Sponsor:
Sheba Medical Center
Conditions:
Major Depressive Disorder
Drug Abuse
Eligibility:
All Genders
18-80 years
Brief Summary
Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In ...
Detailed Description
Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be eva...
Eligibility Criteria
Inclusion
- Patient who participated in ketamine study 1126
Exclusion
- None
Key Trial Info
Start Date :
August 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04824157
Start Date
August 8 2019
End Date
March 30 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chaim Sheba Medical Center
Tel Litwinsky, Israel, 52621